MedTrace Logo

Safety & Efficacy of the J-Valve Ausper System in Patients With Severe Aortic Stenosis and/or Aortic Regurgitation

NCT03025971 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2024-09-19

No results posted yet for this study

Summary

A prospective, multicenter, nonrandomized, single-arm, clinical study.

Conditions

  • Aortic Valve Disease

Interventions

DEVICE

J-Valve Transcatheter Aortic valve replacement

Transapical Transcatheter Aortic Valve Replacement

Sponsors & Collaborators

  • JC Medical, Inc., an affiliate of Edwards Lifesciences LLC

    lead INDUSTRY

Principal Investigators

  • Ji Zhang, MD · CEO, President

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2016-04-30
Completion
2020-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03025971 on ClinicalTrials.gov